We are live on ! Find out more
DTC

Deep Track Capital Portfolio holdings

AUM $6.12B
1-Year Est. Return 144%
This Fund
S&P 500
This Quarter Est. Return
+8.63%
1 Year Est. Return
+144%
3 Year Est. Return
+348.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.12B
AUM Growth
+$30M
Cap. Flow
-$55.4M
Cap. Flow %
-1.78%
Top 10 Hldgs %
52.44%
Holding
76
New
7
Increased
18
Reduced
21
Closed
10

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$114M
2
JBIO
Jade Biosciences
JBIO
+$85.4M
3
AXSM icon
Axsome Therapeutics
AXSM
+$84.9M
4
PCVX icon
Vaxcyte
PCVX
+$45.9M
5
APLS
Apellis Pharmaceuticals
APLS
+$37M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$264M
2
BBIO icon
BridgeBio Pharma
BBIO
+$69.1M
3
GH icon
Guardant Health
GH
+$53.3M
4
AMGN icon
Amgen
AMGN
+$35.2M
5
EWTX icon
Edgewise Therapeutics
EWTX
+$30.8M

Sector Composition

Rank Sector Weight
1 Healthcare 99.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
76
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-2,000,000
Closed -$264M
1 2 3
4

Similar funds

AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Deep Track Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Deep Track Capital held 76 positions worth $3.12B, up 0.97% from $3.09B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deep Track Capital's Q2 2025 filing shows 7 new, 18 increased, 21 reduced and 10 closed positions. Its largest new stake was Jade Biosciences: 2,509,301 shares worth $25.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $264M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier.

  • Deep Track Capital's largest Q2 2025 buy was Jade Biosciences: 2,509,301 shares worth $25.1M.
  • Deep Track Capital added most to Insmed in Q2 2025, an estimated $114M increase.
  • Deep Track Capital's biggest Q2 2025 reduction was BridgeBio Pharma, cutting an estimated $69.1M.
  • Deep Track Capital fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $264M.
  • Deep Track Capital's ten largest holdings make up 52% of its $3.12B portfolio in Q2 2025.
  • Deep Track Capital opened 7 new positions and closed 10 in Q2 2025.
  • Deep Track Capital's portfolio value rose 0.97% quarter-over-quarter to $3.12B.

Based on Deep Track Capital's 13F filing for Q2 2025, filed 14 Aug 2025.